{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T10:13:48Z","timestamp":1696587228107},"reference-count":30,"publisher":"Media Sphere Publishing Group","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z. nevrol. psikhiatr. im. S.S. Korsakova"],"published-print":{"date-parts":[[2020]]},"DOI":"10.17116\/jnevro202012007168","type":"journal-article","created":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T21:02:59Z","timestamp":1597352579000},"page":"68","source":"Crossref","is-referenced-by-count":1,"title":["Botulinum toxin type A (Incobotulinum toxin A) in spastic forms of cerebral palsy: a retrospective analysis of clinical experience"],"prefix":"10.17116","volume":"120","author":[{"given":"A.L.","family":"Kurenkov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.M.","family":"Kuzenkova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.I.","family":"Bursagova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.A.","family":"Klochkova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.V.","family":"Chernikov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Kuznetsova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.S.","family":"Ashrafova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.S.","family":"Kuprianova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6743","reference":[{"key":"key-10.17116\/jnevro202012007168-1","unstructured":"Koman LA, Mooney JF 3rd, Smith B, Goodman A, Mulvaney T. Management of cerebral palsy with botulinum-a toxin: Preliminary investigation. J. Pediatr. Orthop. 1993;13:489-495"},{"key":"key-10.17116\/jnevro202012007168-2","doi-asserted-by":"publisher","DOI":"10.3390\/toxins7051629"},{"key":"key-10.17116\/jnevro202012007168-3","doi-asserted-by":"publisher","DOI":"10.1007\/s40272-019-00344-8"},{"key":"key-10.17116\/jnevro202012007168-4","unstructured":"Koman LA, Mooney JF 3rd, Smith BP, Goodman A, Mulvaney T. Management of spasticity in cerebral palsy with botulinum-A toxin: report of a preliminary, randomized, double-blind trial. J. Pediatr. Orthop. 1994;14(3):299-303"},{"key":"key-10.17116\/jnevro202012007168-5","doi-asserted-by":"crossref","unstructured":"Sutherland DH, Kaufman KR, Wyatt MP, Chambers HG, Mubarak SJ. Double-blind study of botulinum toxin A toxin injections into the gastrocnemius muscle in patients with cerebral palsy. Gait Posture. 1999;10(1):1-9","DOI":"10.1016\/S0966-6362(99)00012-0"},{"key":"key-10.17116\/jnevro202012007168-6","doi-asserted-by":"crossref","unstructured":"Koman LA, Brashear A, Rosenfeld S, Chambers H, Russman B, Rang M, Root L, Ferrari E, Garcia de Yebenes Prous J, Smith BP, Turkel C, Walcott JM, Molloy PT. Botulinum toxin type a neuromuscular blockade in the treatment of equinus foot deformity in cerebral palsy: a multicenter, open-label clinical trial. Pediatrics. 2001;108(5):1062-1071","DOI":"10.1542\/peds.108.5.1062"},{"key":"key-10.17116\/jnevro202012007168-7","doi-asserted-by":"crossref","unstructured":"Baker R, Jasinski M, Maciag-Tymecka I, Michalowska-Mrozek J, Bonikowski M, Carr L, MacLean J, Lin JP, Lynch B, Theologis T, Wendorff J, Eunson P, Cosgrove A. Botulinum toxin treatment of spasticity in diplegic cerebral palsy: a randomized, double-blind, placebo-controlled, dose-ranging study. Dev. Med. Child Neurol. 2002;44(10):666-675","DOI":"10.1111\/j.1469-8749.2002.tb00268.x"},{"key":"key-10.17116\/jnevro202012007168-8","doi-asserted-by":"crossref","unstructured":"Polak F, Morton R, Ward C, Wallace WA, Doderlein L, Siebel A. Double-blind comparison of two doses of botulinum toxin A injected into calf muscle in children with hemiplegic cerebral palsy. Dev Med Child Neurol. 2002;44:551-555","DOI":"10.1111\/j.1469-8749.2002.tb00328.x"},{"key":"key-10.17116\/jnevro202012007168-9","doi-asserted-by":"crossref","unstructured":"Graham HK, Aoki KR, Autti-R\u00e4m\u00f6 I, Boyd RN, Delgado MR, Gaebler-Spira DJ, Gormley ME, Guyer BM, Heinen F, Holton AF, Matthews D, Molenaers G, Motta F, Garc\u00eda Ruiz PJ, Wissel J. Recommendations for the use of botulinum toxin type A in the management of cerebral palsy. Gait Posture. 2000;11(1):67-79. Review","DOI":"10.1016\/S0966-6362(99)00054-5"},{"key":"key-10.17116\/jnevro202012007168-10","doi-asserted-by":"crossref","unstructured":"Koman LA, Paterson Smith B, Balkrishnan R. Spasticity associated with cerebral palsy in children: guidelines for the use of botulinum A toxin. Paediatr. Drugs. 2003;5(1):11-23. Review","DOI":"10.2165\/00128072-200305010-00002"},{"key":"key-10.17116\/jnevro202012007168-11","doi-asserted-by":"publisher","DOI":"10.1017\/S0012162206000041"},{"key":"key-10.17116\/jnevro202012007168-12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2009.09.005"},{"key":"key-10.17116\/jnevro202012007168-13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2010.03126.x"},{"key":"key-10.17116\/jnevro202012007168-14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2010.03127.x"},{"key":"key-10.17116\/jnevro202012007168-15","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181cbcd2f"},{"key":"key-10.17116\/jnevro202012007168-16","doi-asserted-by":"publisher","DOI":"10.1177\/0883073817729918"},{"key":"key-10.17116\/jnevro202012007168-17","doi-asserted-by":"publisher","DOI":"10.1177\/0883073816686910"},{"key":"key-10.17116\/jnevro202012007168-18","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-020-1022-z"},{"key":"key-10.17116\/jnevro202012007168-19","doi-asserted-by":"crossref","unstructured":"Leon-Valenzuela A, Sanchez Palacios J, del Pino Algarrada R. Clinical practice with incobotulinumtoxina (Xeomin) in the treatment of spasticity in children with cerebral palsy. Toxicon. 2016;123:S53","DOI":"10.1016\/j.toxicon.2016.11.150"},{"key":"key-10.17116\/jnevro202012007168-20","doi-asserted-by":"crossref","unstructured":"Hijazi S, Arcas M. Effectiveness and safety assessment of incobotulinumtoxina (Xeomin) injections in the lower-limb muscles of young, low-weight children with cerebral palsy. Toxicon. 2016;123:S39","DOI":"10.1016\/j.toxicon.2016.11.111"},{"key":"key-10.17116\/jnevro202012007168-21","unstructured":"NeuroKids: child neurology workbook (Ed. Prof. F. Heinen). Kohlhammer, 2017"},{"key":"key-10.17116\/jnevro202012007168-22","doi-asserted-by":"crossref","unstructured":"Heinen F, Kanovsk\u00fd P, Schroeder SA, Berweck S, Chambers HG, Dabrowski E, Geister TL, Dersch H, Martinez-Torres FJ, Lehn A, Pulte I, Gaebler-Spira D. Efficacy and safety of IncobotulinumtoxinA for lower-limb spasticity in children and adolescents with cerebral palsy. Toxicon. 2018;156:S44","DOI":"10.1016\/j.toxicon.2018.11.109"},{"key":"key-10.17116\/jnevro202012007168-23","doi-asserted-by":"crossref","unstructured":"Kanovsk\u00fd P, Heinen F, Schroeder SA, Berweck S, Chambers HG, Dabrowski E, Geister TL, Dersch H, Martinez-Torres FJ, Lehn A, Pulte I, Martinez-Torres FJ, Gaebler-Spira D. Long-term safety and efficacy of IncobotulinumtoxinA for lower- or combined upper- and lower-limb spasticity in children and adolescents with cerebral palsy. Toxicon. 2018;156:S56","DOI":"10.1016\/j.toxicon.2018.11.135"},{"key":"key-10.17116\/jnevro202012007168-24","unstructured":"Thomason P, Rodda J, Willoughby K, Graham K. Orthopaedic assessment. In book: Cerebral palsy: science and clinical practice (Eds. B. Dan, M. Mayston, N. Paneth, L. Rosenbloom). London: Mac Keith Press, 2014;287-311"},{"key":"key-10.17116\/jnevro202012007168-25","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-017-1880-y"},{"key":"key-10.17116\/jnevro202012007168-26","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-9-150"},{"key":"key-10.17116\/jnevro202012007168-27","unstructured":"Eliasson AC, Burtner P. Improving Hand Function in Children with Cerebral Palsy. London: Mac Keith Press, 2008"},{"key":"key-10.17116\/jnevro202012007168-28","doi-asserted-by":"crossref","unstructured":"Klochkova OA, Kurenkov AL, Namazova-Baranova LS, Mamedyarov AM. Spasticity patterns of hand muscles and botulinum toxin therapy application in patients with cerebral palsy with upper limb involvment. Pediatricheskaya farmakologiya. 2013;10(5):31-39. (In Russ.)","DOI":"10.15690\/pf.v10i5.820"},{"key":"key-10.17116\/jnevro202012007168-29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2016.04.008"},{"key":"key-10.17116\/jnevro202012007168-30","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro201711711137-44"}],"container-title":["Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T18:55:54Z","timestamp":1696532154000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.mediasphera.ru\/issues\/zhurnal-nevrologii-i-psikhiatrii-im-s-s-korsakova\/2020\/7\/1199772982020071068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020]]}},"alternative-id":["10.17116\/jnevro202012007168"],"URL":"https:\/\/doi.org\/10.17116\/jnevro202012007168","relation":{},"ISSN":["1997-7298"],"issn-type":[{"value":"1997-7298","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}